Oasmia Pharmaceutical AB - Delisted Pink Sheet
Oasmia Pharmaceutical AB is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Oasmia Pharmaceutical was actively traded.
Valuation
Check how we calculate scores
Oasmia Pharmaceutical Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Oasmia Pharmaceutical market risk premium is the additional return an investor will receive from holding Oasmia Pharmaceutical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Oasmia Pharmaceutical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Oasmia Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Oasmia Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | 0.1008 | |||
| Jensen Alpha | 7.13 | |||
| Total Risk Alpha | 2.66 | |||
| Treynor Ratio | 1.21 |
Oasmia Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oasmia Pharmaceutical pink sheet to make a market-neutral strategy. Peer analysis of Oasmia Pharmaceutical could also be used in its relative valuation, which is a method of valuing Oasmia Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Oasmia Pharmaceutical Corporate Management
Elected by the shareholders, the Oasmia Pharmaceutical's board of directors comprises two types of representatives: Oasmia Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Oasmia. The board's role is to monitor Oasmia Pharmaceutical's management team and ensure that shareholders' interests are well served. Oasmia Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Oasmia Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kai Wilkinson | Chief Officer | Profile | |
| Urban Ekelund | IR Mang | Profile | |
| Henrik Rnnberg | Chief Health | Profile | |
| John Cosby | Head Affairs | Profile | |
| Robert Maiorana | Head CFO | Profile | |
| Dzianis Babrou | Head Devel | Profile | |
| Christer MD | Acting Officer | Profile |
Still Interested in Oasmia Pharmaceutical AB?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Oasmia Pink Sheet
If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |